NCT04339504View on ClinicalTrials.gov

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 14, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

SMUP-IA-01(low-dose)

A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10\^6 cells/2mL)

BIOLOGICAL

SMUP-IA-01(mid-dose)

A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10\^7 cells/2mL)

BIOLOGICAL

SMUP-IA-01(high-dose)

A single knee administration of SMUP-IA-01(high-dose, 2.0 x 10\^7 cells/2mL)

Trial Locations (1)

03080

RECRUITING

Seoul national University Hospital, Seoul

All Listed Sponsors
lead

Medipost Co Ltd.

INDUSTRY